Page last updated: 2024-08-26

cholesteryl butanoate and Colonic Neoplasms

cholesteryl butanoate has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrera, G; Chiocchetti, A; Conti, L; Dianzani, C; Dianzani, U; Fantozzi, R; Gasco, P; Gigliotti, CL; Giovarelli, M; Minelli, R; Occhipinti, S; Zara, GP1
Barrera, G; Dianzani, C; Dianzani, U; Fantozzi, R; Gasco, P; Gigliotti, C; Mesturini, R; Minelli, R; Minero, V; Muntoni, E; Pettazzoni, P; Rosa, AC; Serpe, L; Vivenza, N; Zara, GP1

Other Studies

2 other study(ies) available for cholesteryl butanoate and Colonic Neoplasms

ArticleYear
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.
    British journal of pharmacology, 2013, Volume: 170, Issue:2

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol Esters; Colonic Neoplasms; Female; Humans; Lipids; Male; Mice; Mice, SCID; Nanoparticles; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2013
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.
    British journal of pharmacology, 2012, Volume: 166, Issue:2

    Topics: Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cholesterol Esters; Colonic Neoplasms; Drug Carriers; Human Umbilical Vein Endothelial Cells; Humans; Nanoparticles

2012